Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs

Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs Publisher

Salehbayat M¹ ; Abolfazli R² ; Mohebbi N^{3, 4} ; Savar SM⁴ ; Shalviri G⁴ ; Gholami K^{3, 4}

Show Affiliations

1. School of Pharmacy, International Campus, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Neurology, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Clinical Pharmacy, Rational Use of Drugs Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4. Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran

Source: Basic and Clinical Neuroscience Published:2023

Abstract

Introduction: High frequency of adverse drug reactions (ADRs) challenges multiple sclerosis (MS) treatment. This study aims to assess the nature and frequency of ADRs induced by MS medications in an observational cross-sectional study. Methods: ADRs of all outpatients who had seen a neurologist and had received at least one disease-modifying therapy (DMT) for MS during the last three months were investigated. Results: A total of 484 ADRs were detected in these patients. The preventability rate was 5.9%, and 0.61% of reactions were serious. Conclusion: The high frequency of adverse drug reactions in this study shows a strong need for strategy planning to increase patients’ adherence to treatment. © 2023 Iran University of Medical Sciences. All rights reserved.

Style	Citing Format
MLA	Salehbayat M, et al.. "Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs." Basic and Clinical Neuroscience, vol. 14, no. 6, 2023, pp. 879-884.
APA	Salehbayat M, Abolfazli R, Mohebbi N, Savar SM, Shalviri G, Gholami K (2023). Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs. Basic and Clinical Neuroscience, 14(6), 879-884.
Chicago	Salehbayat M, Abolfazli R, Mohebbi N, Savar SM, Shalviri G, Gholami K. "Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs." Basic and Clinical Neuroscience 14, no. 6 (2023): 879-884.
Harvard	Salehbayat M et al. (2023) 'Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs', Basic and Clinical Neuroscience, 14(6), pp. 879-884.
Vancouver	Salehbayat M, Abolfazli R, Mohebbi N, Savar SM, Shalviri G, Gholami K. Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs. Basic and Clinical Neuroscience. 2023;14(6):879-884.
BibTex	@article{ author = {Salehbayat M and Abolfazli R and Mohebbi N and Savar SM and Shalviri G and Gholami K}, title = {Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs}, journal = {Basic and Clinical Neuroscience}, volume = {14}, number = {6}, pages = {879-884}, year = {2023} }
RIS	TY - JOUR AU - Salehbayat M AU - Abolfazli R AU - Mohebbi N AU - Savar SM AU - Shalviri G AU - Gholami K TI - Adverse Drug Reactions of Multiple Sclerosis Diseasemodifying Drugs JO - Basic and Clinical Neuroscience VL - 14 IS - 6 SP - 879 EP - 884 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract